KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Net Margin (2020 - 2025)

Historic Net Margin for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to 207.93%.

  • Ginkgo Bioworks Holdings' Net Margin fell 1445900.0% to 207.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 188.0%, marking a year-over-year increase of 1107700.0%. This contributed to the annual value of 240.94% for FY2024, which is 1141400.0% up from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Net Margin is 207.93%, which was down 1445900.0% from 121.56% recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Net Margin ranged from a high of 63.34% in Q3 2024 and a low of 1080.85% during Q4 2021
  • Moreover, its 5-year median value for Net Margin was 245.25% (2024), whereas its average is 356.92%.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -9361100bps in 2021, then soared by 9047500bps in 2022.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Net Margin stood at 1080.85% in 2021, then skyrocketed by 84bps to 176.1% in 2022, then crashed by -246bps to 609.1% in 2023, then surged by 60bps to 245.25% in 2024, then increased by 15bps to 207.93% in 2025.
  • Its last three reported values are 207.93% in Q3 2025, 121.56% for Q2 2025, and 188.25% during Q1 2025.